Francesco Massari

18.6k total citations · 7 hit papers
479 papers, 9.9k citations indexed

About

Francesco Massari is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Francesco Massari has authored 479 papers receiving a total of 9.9k indexed citations (citations by other indexed papers that have themselves been cited), including 259 papers in Pulmonary and Respiratory Medicine, 181 papers in Oncology and 143 papers in Surgery. Recurrent topics in Francesco Massari's work include Renal cell carcinoma treatment (127 papers), Cancer Immunotherapy and Biomarkers (113 papers) and Prostate Cancer Treatment and Research (77 papers). Francesco Massari is often cited by papers focused on Renal cell carcinoma treatment (127 papers), Cancer Immunotherapy and Biomarkers (113 papers) and Prostate Cancer Treatment and Research (77 papers). Francesco Massari collaborates with scholars based in Italy, United States and Spain. Francesco Massari's co-authors include Matteo Santoni, Rodolfo Montironi, Veronica Mollica, Alessandro Rizzo, Liang Cheng, Antonio López-Beltrán, Marina Scarpelli, Alessia Cimadamore, Giampaolo Tortora and Matteo Rosellini and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Francesco Massari

450 papers receiving 9.7k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cardiac resynchronization therapy tailored by echocardiographic evaluation of ventricular asynchrony

2002 528 citations Massimo Iacoviello, Francesco Massari et al. profile →
Immune Checkpoint Inhibitors for the Treatment of Bladder Cancer

2021 187 citations Antonio López-Beltrán, Alessia Cimadamore et al. Cancers profile →
Prognostic and predictive biomarkers for immunotherapy in advanced renal cell carcinoma

2022 138 citations Matteo Rosellini, Andrea Marchetti et al. profile →
The impact of gender on The efficacy of immune checkpoint inhibitors in cancer patients: The MOUSEION-01 study

2022 123 citations Matteo Santoni, Alessandro Rizzo et al. Critical Reviews in Oncology/Hematology profile →
Complete remissions following immunotherapy or immuno-oncology combinations in cancer patients: the MOUSEION-03 meta-analysis

2023 117 citations Matteo Santoni, Alessandro Rizzo et al. profile →
The impact of ECOG performance status on efficacy of immunotherapy and immune-based combinations in cancer patients: the MOUSEION-06 study

2023 115 citations Veronica Mollica, Alessandro Rizzo et al. profile →
Hypertransaminasemia in cancer patients receiving immunotherapy and immune-based combinations: the MOUSEION-05 study

2023 107 citations Alessandro Rizzo, Veronica Mollica et al. profile →

Peers

Francesco Massari

PRM

ONCOL

SURGE

Tadashi Hasegawa Japan

Koji Tanaka Japan

Hiroshi Wada Japan

Marc K. Halushka United States

Yoshiharu Sakai Japan

Masato Kusunoki Japan

Mototsugu Oya Japan

Tsutomu Masaki Japan

Martin Pichler Austria

Yoshihiro Kakeji Japan

Tadashi Hasegawa Japan

Francesco Massari

5.0k ×1.3

PRM

3.6k ×1.1

ONCOL

2.8k ×1.0

1.8k ×0.8

SURGE

1.2k ×0.6

Citations per year, relative to Francesco Massari Francesco Massari (= 1×) peers Tadashi Hasegawa

Countries citing papers authored by Francesco Massari

Since Specialization

Citations

This map shows the geographic impact of Francesco Massari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesco Massari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesco Massari more than expected).

Fields of papers citing papers by Francesco Massari

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francesco Massari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesco Massari. The network helps show where Francesco Massari may publish in the future.

Co-authorship network of co-authors of Francesco Massari

This figure shows the co-authorship network connecting the top 25 collaborators of Francesco Massari. A scholar is included among the top collaborators of Francesco Massari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francesco Massari. Francesco Massari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Scicchitano, Pietro, Massimo Iacoviello, Stefano Albani, et al.. (2025). Congestion and systemic inflammation in acute heart failure: correlations and prognostic role. Frontiers in Cardiovascular Medicine. 12. 1695500–1695500.

Ricci, Costantino, Francesca Ambrosi, Francesco Vasuri, et al.. (2025). Immunohistochemical expression of Nectin-4 and potential implications for enfortumab vedotin therapy in germ cell tumors of the testis: a preliminary study. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 488(3). 499–510. 2 indexed citations

Monteiro, Fernando Sabino Marques, Andrey Soares, Veronica Mollica, et al.. (2024). Efficacy of immune checkpoint inhibitors combinations as first-line systemic treatment in patients with advanced urothelial carcinoma: A systematic review and network meta-analysis. Critical Reviews in Oncology/Hematology. 196. 104321–104321. 7 indexed citations

Vitale, Elsa, Deniz Can Güven, Raffaella Massafra, et al.. (2024). Sex differences in adverse events among cancer patients receiving immune checkpoint inhibitors: the MOUSEION-07 systematic review and meta-analysis. Scientific Reports. 14(1). 28309–28309. 8 indexed citations

Ricci, Costantino, Francesca Ambrosi, Francesca Giunchi, et al.. (2023). FoxA2 is a reliable marker for the diagnosis of yolk sac tumour postpubertal‐type. Histopathology. 83(3). 465–476. 10 indexed citations

Maloberti, Thais, Antonio De Leo, Elisa Gruppioni, et al.. (2023). Multi-Gene Next-Generation Sequencing Panel for Analysis of BRCA1/BRCA2 and Homologous Recombination Repair Genes Alterations Metastatic Castration-Resistant Prostate Cancer. International Journal of Molecular Sciences. 24(10). 8940–8940. 3 indexed citations

Marchetti, Andrea, Matteo Rosellini, Elisa Tassinari, et al.. (2022). PARP Inhibitors and Radiometabolic Approaches in Metastatic Castration-Resistant Prostate Cancer: What’s Now, What’s New, and What’s Coming?. Cancers. 14(4). 907–907. 11 indexed citations

Mollica, Veronica, Francesco Massari, Alessandro Rizzo, et al.. (2022). Genomics and Immunomics in the Treatment of Urothelial Carcinoma. Current Oncology. 29(5). 3499–3518. 9 indexed citations

Mollica, Veronica, Andrea Marchetti, Matteo Rosellini, et al.. (2021). An Insight on Novel Molecular Pathways in Metastatic Prostate Cancer: A Focus on DDR, MSI and AKT. International Journal of Molecular Sciences. 22(24). 13519–13519. 18 indexed citations

10.

Mollica, Veronica, Alessandro Rizzo, Matteo Rosellini, et al.. (2021). Bone Targeting Agents in Patients with Metastatic Prostate Cancer: State of the Art. Cancers. 13(3). 546–546. 37 indexed citations

11.

Basso, Umberto, Giuseppe Procopio, Giuseppe Fornarini, et al.. (2021). Safety and Efficacy of Tivozanib in First-Line mRCC: A Multicenter Compassionate-Use Study (Meet-Uro 16). Oncology. 99(12). 747–755. 2 indexed citations

12.

Aurilio, Gaetano, Matteo Santoni, Francesco Massari, et al.. (2021). Metabolomic Profiling in Renal Cell Carcinoma Patients: News and Views. Cancers. 13(20). 5229–5229. 13 indexed citations

13.

Cimadamore, Alessia, Roberta Mazzucchelli, Antonio López-Beltrán, et al.. (2021). Prostate Cancer in 2021: Novelties in Prognostic and Therapeutic Biomarker Evaluation. Cancers. 13(14). 3471–3471. 8 indexed citations

14.

Santoni, Matteo, Francesco Piva, Camillo Porta, et al.. (2020). Artificial Neural Networks as a Way to Predict Future Kidney Cancer Incidence in the United States. Clinical Genitourinary Cancer. 19(2). e84–e91. 20 indexed citations

15.

Giunchi, Francesca, Francesco Massari, Annalisa Altimari, et al.. (2020). Dual TMPRSS2:ERG Fusion in a Patient with Lung and Prostate Cancers. Diagnostics. 10(12). 1109–1109. 5 indexed citations

16.

Aurilio, Gaetano, Alessia Cimadamore, Matteo Santoni, et al.. (2020). New Frontiers in Prostate Cancer Treatment: Are We Ready for Drug Combinations with Novel Agents?. Cells. 9(6). 1522–1522. 8 indexed citations

17.

Giunchi, Francesca, Elisa Gruppioni, Annalisa Altimari, et al.. (2020). Similarities and Differences between Clear Cell Tubulo-Papillary and Conventional Clear Cell Renal Cell Carcinoma: A Comparative Phenotypical and Mutational Analysis. Diagnostics. 10(2). 123–123. 3 indexed citations

18.

Cariani, Alessia, Elisabetta Cilli, Francesco Massari, et al.. (2019). Comparison and optimization of genetic tools used for the identification of ancient fish remains recovered from archaeological excavations and museum collections in the Mediterranean region. International Journal of Osteoarchaeology. 29(3). 365–376. 5 indexed citations

19.

Conteduca, Vincenza, Orazio Caffo, Cristian Lolli, et al.. (2017). Long‐term clinical impact of PSA surge in castration‐resistant prostate cancer patients treated with abiraterone. The Prostate. 77(9). 1012–1019. 7 indexed citations

20.

Ghedini, Pietro, Irene Bossert, Lucia Zanoni, et al.. (2017). Liver metastases from prostate cancer at 11C-Choline PET/CT: a multicenter, retrospective analysis. European Journal of Nuclear Medicine and Molecular Imaging. 45(5). 751–758. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact